Details of Ethics Approval
The trial was approved by the United Kingdom Medicines and Healthcare
Products Regulatory Authority (MHRA), West Midlands-The black Country
Research Ethics Committee (REC Ref No.: 14/WM/0093, Date: 06/05/2014),
and the research and development departments at the 9 participating NHS
hospitals.